J D Dockerty1, D C G Skegg, S M Williams. 1. Department of Preventive and Social Medicine, University of Otago, PO Box 213, Dunedin, New Zealand. john.dockerty@stonebow.otago.ac.nz
Abstract
OBJECTIVE: To assess the financial impact of childhood cancer on families. METHODS: This was a cross-sectional survey of parents caring for children who were diagnosed with cancer during the period 1990-1993. Self-administered questionnaires were completed by the parents of 237 children from throughout New Zealand with different types of cancer. Dollar amounts were adjusted to the equivalent of December 2000. RESULTS: Eighty-six per cent of the 192 living children were well or in remission. A further 45 children had died. The average extra amount spent, because of the child's illness, by the family of a living child in the 30 days prior to participation in the study was NZ$220 (SD NZ$330). On average, this was 13% of the family income after tax. After reported entitlement to compensation from various sources was allowed for, families were left with a mean deficit of NZ$157 (SD NZ$278) for the 30 days. Twelve families had a shortfall of more than NZ$500, including three families that had a shortfall of more than NZ$1000. Expenditure was greater for those whose children spent more time in hospital (P = 0.003). There was no significant association between the total cost and the distance travelled to the treatment centre (P = 0.96). For 24 families, after-tax income in the month prior to participation in the study was at least NZ$500 lower than it had been in the month before the child's diagnosis. Thirty-seven per cent of families reported that they needed to borrow money because of the financial effects of the child's illness. Bereaved parents spent an average of NZ$3065 (SD NZ$2168) on funeral expenses. CONCLUSION: There is a large financial burden on families who have a child with cancer.
OBJECTIVE: To assess the financial impact of childhood cancer on families. METHODS: This was a cross-sectional survey of parents caring for children who were diagnosed with cancer during the period 1990-1993. Self-administered questionnaires were completed by the parents of 237 children from throughout New Zealand with different types of cancer. Dollar amounts were adjusted to the equivalent of December 2000. RESULTS: Eighty-six per cent of the 192 living children were well or in remission. A further 45 children had died. The average extra amount spent, because of the child's illness, by the family of a living child in the 30 days prior to participation in the study was NZ$220 (SD NZ$330). On average, this was 13% of the family income after tax. After reported entitlement to compensation from various sources was allowed for, families were left with a mean deficit of NZ$157 (SD NZ$278) for the 30 days. Twelve families had a shortfall of more than NZ$500, including three families that had a shortfall of more than NZ$1000. Expenditure was greater for those whose children spent more time in hospital (P = 0.003). There was no significant association between the total cost and the distance travelled to the treatment centre (P = 0.96). For 24 families, after-tax income in the month prior to participation in the study was at least NZ$500 lower than it had been in the month before the child's diagnosis. Thirty-seven per cent of families reported that they needed to borrow money because of the financial effects of the child's illness. Bereaved parents spent an average of NZ$3065 (SD NZ$2168) on funeral expenses. CONCLUSION: There is a large financial burden on families who have a child with cancer.
Authors: F Njuguna; S Mostert; A Seijffert; J Musimbi; S Langat; R H M van der Burgt; J Skiles; M N Sitaresmi; P M van de Ven; G J L Kaspers Journal: Support Care Cancer Date: 2014-10-17 Impact factor: 3.603
Authors: Veronica Dussel; Kira Bona; John A Heath; Joanne M Hilden; Jane C Weeks; Joanne Wolfe Journal: J Clin Oncol Date: 2011-01-04 Impact factor: 44.544
Authors: Mark N Fluchel; Anne C Kirchhoff; Julia Bodson; Carol Sweeney; Sandra L Edwards; Qian Ding; Gregory J Stoddard; Anita Y Kinney Journal: Pediatr Blood Cancer Date: 2014-08-17 Impact factor: 3.167
Authors: Rachel Thienprayoon; Emily Marks; Maria Funes; Louizza Maria Martinez-Puente; Naomi Winick; Simon Craddock Lee Journal: J Palliat Med Date: 2015-11-30 Impact factor: 2.947